Naoki Morito

2.4k total citations
51 papers, 1.9k citations indexed

About

Naoki Morito is a scholar working on Molecular Biology, Nephrology and Immunology. According to data from OpenAlex, Naoki Morito has authored 51 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 16 papers in Nephrology and 15 papers in Immunology. Recurrent topics in Naoki Morito's work include Renal Diseases and Glomerulopathies (11 papers), Genomics, phytochemicals, and oxidative stress (7 papers) and Chronic Kidney Disease and Diabetes (6 papers). Naoki Morito is often cited by papers focused on Renal Diseases and Glomerulopathies (11 papers), Genomics, phytochemicals, and oxidative stress (7 papers) and Chronic Kidney Disease and Diabetes (6 papers). Naoki Morito collaborates with scholars based in Japan, United States and Switzerland. Naoki Morito's co-authors include Satoru Takahashi, Masayuki Yamamoto, Keigyou Yoh, Ken Itoh, Aki Hirayama, Akio Kôyama, Homare Shimohata, Michito Hamada, Takashi Moriguchi and Takashi Kudo and has published in prestigious journals such as The Journal of Immunology, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Naoki Morito

50 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naoki Morito Japan 20 1.1k 442 382 328 197 51 1.9k
Lynn Htet Htet Aung China 26 1.0k 0.9× 401 0.9× 215 0.6× 155 0.5× 212 1.1× 62 2.0k
Wenguang Feng United States 20 559 0.5× 161 0.4× 359 0.9× 218 0.7× 209 1.1× 41 1.5k
Carol Dangelmaier United States 33 1.0k 0.9× 305 0.7× 448 1.2× 317 1.0× 184 0.9× 89 3.1k
Wai Han Yiu Hong Kong 23 787 0.7× 219 0.5× 467 1.2× 286 0.9× 207 1.1× 53 2.1k
Theodore C. Simon United States 20 821 0.8× 285 0.6× 150 0.4× 356 1.1× 95 0.5× 28 1.5k
Yumi Takiyama Japan 21 584 0.5× 370 0.8× 151 0.4× 168 0.5× 425 2.2× 48 1.4k
Chunyan Gu China 24 1.5k 1.4× 368 0.8× 142 0.4× 205 0.6× 227 1.2× 93 2.3k
Matilde Alique Spain 26 846 0.8× 200 0.5× 353 0.9× 79 0.2× 123 0.6× 64 1.8k
Sally P.A. McCormick New Zealand 25 632 0.6× 1.0k 2.3× 327 0.9× 193 0.6× 437 2.2× 59 2.1k
Samy L. Habib United States 24 1.0k 1.0× 231 0.5× 141 0.4× 115 0.4× 168 0.9× 72 1.8k

Countries citing papers authored by Naoki Morito

Since Specialization
Citations

This map shows the geographic impact of Naoki Morito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoki Morito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoki Morito more than expected).

Fields of papers citing papers by Naoki Morito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoki Morito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoki Morito. The network helps show where Naoki Morito may publish in the future.

Co-authorship network of co-authors of Naoki Morito

This figure shows the co-authorship network connecting the top 25 collaborators of Naoki Morito. A scholar is included among the top collaborators of Naoki Morito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoki Morito. Naoki Morito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Daassi, Dhouha, Toshiaki Usui, Naoki Morito, et al.. (2024). MAFB in Macrophages Regulates Prostaglandin E2–Mediated Lipid Mediator Class Switch through ALOX15 in Ischemic Acute Kidney Injury. The Journal of Immunology. 213(8). 1212–1224. 2 indexed citations
2.
Morito, Naoki, Masami Ojima, Shun Ishibashi, et al.. (2023). Transcription factor c-Maf deletion improves streptozotocin-induced diabetic nephropathy by directly regulating Sglt2 and Glut2. JCI Insight. 8(6). 6 indexed citations
3.
Maruyama, Hiroki, Atsushi Izawa, Naoki Morito, et al.. (2021). Plasma Globotriaosylsphingosine and ?-Galactosidase A Activity as a Combined Screening Biomarker for Fabry Disease in a Large Japanese Cohort. Current Issues in Molecular Biology. 43(1). 389–404. 7 indexed citations
4.
Saito, Chie, Kei Nagai, Keisei Kosaki, et al.. (2021). Ratio of serum creatinine to cystatin C is related to leg strength in predialysis CKD patients. Clinical and Experimental Nephrology. 25(10). 1079–1086. 1 indexed citations
5.
Okada, Risa, Takashi Sato, Hisashi Narimatsu, et al.. (2020). Mice lacking core 1-derived O-glycan in podocytes develop transient proteinuria, resulting in focal segmental glomerulosclerosis. Biochemical and Biophysical Research Communications. 523(4). 1007–1013. 6 indexed citations
6.
Kai, Hirayasu, Ryota Ishii, Akiko Fujita, et al.. (2020). A case report of progressive multifocal leukoencephalopathy during steroid treatment for ANCA-associated renal vasculitis. CEN Case Reports. 9(4). 354–358. 2 indexed citations
7.
Kai, Hirayasu, Megumi Watanabe, Noriaki Moriyama, et al.. (2015). Two autosomal dominant polycystic kidney (ADPKD) cases with advanced renal dysfunction, effectively treated with tolvaptan. CEN Case Reports. 5(1). 87–90. 2 indexed citations
8.
Kihara, Masao, Junichiro Nakata, Masako Otani, et al.. (2014). O-Linked Glycosylation Determines the Nephritogenic Potential of IgA Rheumatoid Factor. Journal of the American Society of Nephrology. 25(6). 1282–1290. 5 indexed citations
9.
Okubo, Reiko, Hirayasu Kai, Masahide Kondo, et al.. (2013). Health-related quality of life and prognosis in patients with chronic kidney disease: a 3-year follow-up study. Clinical and Experimental Nephrology. 18(5). 697–703. 25 indexed citations
10.
Harada, Nobuhiko, Koichi Ito, Tomonori Hosoya, et al.. (2012). Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation. Free Radical Biology and Medicine. 53(12). 2256–2262. 62 indexed citations
11.
Baudino, Lucie, Kumiko Yoshinobu, Naoki Morito, Marie‐Laure Santiago‐Raber, & Shozo Izui. (2010). Role of endogenous retroviruses in murine SLE. Autoimmunity Reviews. 10(1). 27–34. 42 indexed citations
12.
Shimohata, Homare, et al.. (2009). Overexpression of T-bet in T cells accelerates autoimmune glomerulonephritis in mice with a dominant Th1 background. Journal of Nephrology. 22(1). 123–129. 10 indexed citations
13.
Shimohata, Homare, Keigyou Yoh, Akiko Fujita, et al.. (2009). MafA-deficient and beta cell-specific MafK-overexpressing hybrid transgenic mice develop human-like severe diabetic nephropathy. Biochemical and Biophysical Research Communications. 389(2). 235–240. 12 indexed citations
14.
Baudino, Lucie, Kumiko Yoshinobu, Naoki Morito, et al.. (2008). Dissection of Genetic Mechanisms Governing the Expression of Serum Retroviral gp70 Implicated in Murine Lupus Nephritis. The Journal of Immunology. 181(4). 2846–2854. 19 indexed citations
15.
Yamada, Akiko, Keigyou Yoh, Takako Nakano, et al.. (2007). Th1 and Type 1 Cytotoxic T Cells Dominate Responses in T-bet Overexpression Transgenic Mice That Develop Contact Dermatitis. The Journal of Immunology. 178(1). 605–612. 39 indexed citations
16.
Shimohata, Homare, Keigyou Yoh, Naoki Morito, et al.. (2006). MafK overexpression in pancreatic β-cells caused impairment of glucose-stimulated insulin secretion. Biochemical and Biophysical Research Communications. 346(3). 671–680. 9 indexed citations
17.
Zhang, Chuan, Takashi Moriguchi, Ayako Harada, et al.. (2005). MafA Is a Key Regulator of Glucose-Stimulated Insulin Secretion. Molecular and Cellular Biology. 25(12). 4969–4976. 379 indexed citations
18.
Hirayama, Aki, Keigyou Yoh, Sohji Nagase, et al.. (2003). EPR imaging of reducing activity in Nrf2 transcriptional factor-deficient mice. Free Radical Biology and Medicine. 34(10). 1236–1242. 75 indexed citations
19.
Morito, Naoki, Keigyou Yoh, Ken Itoh, et al.. (2003). Nrf2 regulates the sensitivity of death receptor signals by affecting intracellular glutathione levels. Oncogene. 22(58). 9275–9281. 97 indexed citations
20.
Yoh, Keigyou, Ken Itoh, Akiko Enomoto, et al.. (2001). Nrf2-deficient female mice develop lupus-like autoimmune nephritis11See Editorial by Byrd and Thomas, p. 1606.. Kidney International. 60(4). 1343–1353. 299 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026